vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $31.1M, roughly 1.6× LIFECORE BIOMEDICAL, INC. \DE\). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -32.1%, a 27.0% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -14.2%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $25.0K). Over the past eight quarters, READING INTERNATIONAL INC's revenue compounded faster (5.6% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
LFCR vs RDI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $50.3M |
| Net Profit | $-10.0M | $-2.6M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | -1.9% |
| Net Margin | -32.1% | -5.1% |
| Revenue YoY | -4.5% | -14.2% |
| Net Profit YoY | -52.0% | -14.5% |
| EPS (diluted) | $-0.29 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $50.3M | ||
| Q3 25 | $31.1M | $52.2M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | $35.2M | $40.2M | ||
| Q4 24 | $32.6M | $58.6M | ||
| Q3 24 | $24.7M | $60.1M | ||
| Q2 24 | — | $46.8M | ||
| Q1 24 | $35.7M | $45.1M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-10.0M | $-4.2M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | $-14.8M | $-4.8M | ||
| Q4 24 | $-6.6M | $-2.2M | ||
| Q3 24 | $-16.2M | $-7.0M | ||
| Q2 24 | — | $-12.8M | ||
| Q1 24 | $15.6M | $-13.2M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | -1.9% | ||
| Q3 25 | -9.9% | -0.6% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | -25.7% | -17.2% | ||
| Q4 24 | -6.0% | 2.6% | ||
| Q3 24 | -46.9% | -0.6% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | -2.5% | -16.7% |
| Q4 25 | — | -5.1% | ||
| Q3 25 | -32.1% | -8.0% | ||
| Q2 25 | — | -4.4% | ||
| Q1 25 | -42.0% | -11.8% | ||
| Q4 24 | -20.2% | -3.8% | ||
| Q3 24 | -65.7% | -11.7% | ||
| Q2 24 | — | -27.4% | ||
| Q1 24 | 43.8% | -29.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.29 | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | $-0.47 | $-0.21 | ||
| Q4 24 | $-0.25 | $-0.11 | ||
| Q3 24 | $-0.53 | $-0.31 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | $0.42 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $10.5M |
| Total DebtLower is stronger | $136.0M | $185.1M |
| Stockholders' EquityBook value | $-10.5M | $-18.2M |
| Total Assets | $235.2M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.5M | ||
| Q3 25 | $18.9M | $8.1M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | $5.4M | $5.9M | ||
| Q4 24 | $9.5M | $12.4M | ||
| Q3 24 | — | $10.1M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | $202.7M | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $-18.2M | ||
| Q3 25 | $-10.5M | $-12.1M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | $2.2M | $-8.1M | ||
| Q4 24 | $15.4M | $-4.4M | ||
| Q3 24 | $-3.9M | $1.6M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | $17.7M | $18.0M |
| Q4 25 | — | $434.9M | ||
| Q3 25 | $235.2M | $435.2M | ||
| Q2 25 | — | $438.1M | ||
| Q1 25 | $237.7M | $441.0M | ||
| Q4 24 | $255.4M | $471.0M | ||
| Q3 24 | $246.8M | $495.7M | ||
| Q2 24 | — | $494.9M | ||
| Q1 24 | $246.2M | $494.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $4.3M |
| Free Cash FlowOCF − Capex | $25.0K | $4.1M |
| FCF MarginFCF / Revenue | 0.1% | 8.2% |
| Capex IntensityCapex / Revenue | 5.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.3M | ||
| Q3 25 | $1.8M | $295.0K | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | $1.2M | $-7.7M | ||
| Q4 24 | $-6.1M | $8.0M | ||
| Q3 24 | $-613.0K | $1.3M | ||
| Q2 24 | — | $-10.4M | ||
| Q1 24 | $-1.4M | $-2.8M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | $25.0K | $-246.0K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | $-4.3M | $-8.0M | ||
| Q4 24 | $-8.6M | $7.0M | ||
| Q3 24 | $-4.0M | $-1.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | $-7.8M | $-4.7M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | 0.1% | -0.5% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | -12.1% | -19.8% | ||
| Q4 24 | -26.3% | 12.0% | ||
| Q3 24 | -16.3% | -1.8% | ||
| Q2 24 | — | -22.7% | ||
| Q1 24 | -21.8% | -10.4% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 5.6% | 1.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | 15.5% | 0.6% | ||
| Q4 24 | 7.5% | 1.7% | ||
| Q3 24 | 13.9% | 4.0% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | 17.8% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
